Literature DB >> 25227493

Vγ2Vδ2 T cell Costimulation Increases NK cell Killing of Monocyte-derived Dendritic Cells.

Cristiana Cairo1, Naveen Surendran, Kristina M Harris, Krystyna Mazan-Mamczarz, Yukimi Sakoda, Felisa Diaz-Mendez, Koji Tamada, Ronald B Gartenhaus, Dean L Mann, C David Pauza.   

Abstract

Interactions between NK and dendritic cells (DC) affect maturation and function of both cell populations, including NK killing of DC (editing) that is important for controlling the quality of immune responses. We also know that antigen-stimulated Vγ2Vδ2 T cells costimulate NK cells via 4-1BB to enhance killing of tumor cell lines but we do not know what regulates 4-1BB expression or whether other NK effector functions including DC killing, might also be influenced by NK:γδ T cell cross talk. Here we show that antigen-stimulated γδ T cells costimulate NK through ICOS:ICOSL and this signal increases NK killing of autologous DC. Effects of NK:γδ T cell co-culture, which could be reproduced with soluble ICOS-Fc fusion protein, included increased CD69 and 4-1BB expression, IFN-γ, TNF-α, MIP-1β, I-309, RANTES and sFasL production, as well as elevated mRNA levels for costimulatory receptors OX40 (TNFRSF4) and GITR (TNFRSF18). Thus, ICOS/ICOSL costimulation of NK by Vγ2Vδ2 T cells had broad effects on NK phenotype and effector functions. The NK γδ T cell cross talk links innate and antigen-specific lymphocyte responses in the control of cytotoxic effector function and dendritic cell killing. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  zzm321990ICOSzzm321990; Costimulation; Dendritic cell; Gamma Delta T cell; NK cell

Year:  2014        PMID: 25227493      PMCID: PMC4557679          DOI: 10.1111/imm.12386

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

1.  Recognition of autologous dendritic cells by human NK cells.

Authors:  E Carbone; G Terrazzano; G Ruggiero; D Zanzi; A Ottaiano; C Manzo; K Kärre; S Zappacosta
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

2.  IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

Authors:  Galit Alter; Daniel Kavanagh; Suzannah Rihn; Rutger Luteijn; David Brooks; Michael Oldstone; Jan van Lunzen; Marcus Altfeld
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

3.  Complementary function of gamma delta T-lymphocytes and dendritic cells in the response to isopentenyl-pyrophosphate and lipopolysaccharide antigens.

Authors:  Angelo Martino; Rita Casetti; Alessandra D'Alessandri; Alessandra Sacchi; Fabrizio Poccia
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

4.  Activation of V gamma 9V delta 2 T cells by NKG2D.

Authors:  Bladimiro Rincon-Orozco; Volker Kunzmann; Philine Wrobel; Dieter Kabelitz; Alexander Steinle; Thomas Herrmann
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

5.  NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

Authors:  Claudia Semino; Giovanna Angelini; Alessandro Poggi; Anna Rubartelli
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

6.  Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.

Authors:  Marie-Thérèse Melki; Héla Saïdi; Alexandre Dufour; Jean-Christophe Olivo-Marin; Marie-Lise Gougeon
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

7.  IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.

Authors:  Peter Dubsky; Hiroaki Saito; Marylene Leogier; Carole Dantin; John E Connolly; Jacques Banchereau; A Karolina Palucka
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

8.  Peripheral selection of antigen receptor junctional features in a major human gamma delta subset.

Authors:  F Davodeau; M A Peyrat; M M Hallet; I Houde; H Vie; M Bonneville
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

9.  Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.

Authors:  Barbara Morandi; Lorenzo Mortara; Laura Chiossone; Roberto S Accolla; Maria Cristina Mingari; Lorenzo Moretta; Alessandro Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

10.  Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.

Authors:  Diego Piccioli; Silverio Sbrana; Emiliano Melandri; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  12 in total

1.  Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.

Authors:  Alanna S Murday; Suchita Chaudhry; C David Pauza
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

2.  Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation.

Authors:  Haoting Hsu; Sarah Boudova; Godfrey Mvula; Titus H Divala; Randy G Mungwira; Christopher Harman; Miriam K Laufer; C David Pauza; Cristiana Cairo
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

3.  Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection.

Authors:  Iskra Tuero; David Venzon; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2016-11-04       Impact factor: 5.422

4.  Phosphoantigen-Stimulated γδ T Cells Suppress Natural Killer-Cell Responses to Missing-Self.

Authors:  Katherine Walwyn-Brown; Jason Pugh; Alexander T H Cocker; Niassan Beyzaie; Bernhard B Singer; Daniel Olive; Lisbeth A Guethlein; Peter Parham; Zakia Djaoud
Journal:  Cancer Immunol Res       Date:  2022-05-03       Impact factor: 12.020

Review 5.  γδ T Cells in HIV Disease: Past, Present, and Future.

Authors:  C David Pauza; Bhawna Poonia; Haishan Li; Cristiana Cairo; Suchita Chaudhry
Journal:  Front Immunol       Date:  2015-01-30       Impact factor: 7.561

6.  Development of interleukin-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus.

Authors:  Terkild Brink Buus; Jonas Damgård Schmidt; Charlotte Menné Bonefeld; Carsten Geisler; Jens Peter Holst Lauritsen
Journal:  Oncotarget       Date:  2016-04-12

Review 7.  Protective Role of γδ T Cells in Different Pathogen Infections and Its Potential Clinical Application.

Authors:  Yueshui Zhao; Ling Lin; Zhangang Xiao; Mingxing Li; Xu Wu; Wanping Li; Xiaobing Li; Qijie Zhao; Yuanlin Wu; Hanyu Zhang; Jianhua Yin; Lingling Zhang; Chi Hin Cho; Jing Shen
Journal:  J Immunol Res       Date:  2018-07-10       Impact factor: 4.818

8.  γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells.

Authors:  Meifang Liu; Yuan Hu; Yi Yuan; Zhigang Tian; Cai Zhang
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

Review 9.  Boosting the Immune System for HIV Cure: A γδ T Cell Perspective.

Authors:  Brendan T Mann; Edward Sambrano; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 6.073

Review 10.  Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.

Authors:  C David Pauza; Mei-Ling Liou; Tyler Lahusen; Lingzhi Xiao; Rena G Lapidus; Cristiana Cairo; Haishan Li
Journal:  Front Immunol       Date:  2018-06-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.